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ABSTRACT
Objective: To investigate the association between
alcohol consumption and mortality in patients recently
diagnosed with mild Alzheimer’s disease (AD).
Design: A post hoc analysis study based on a clinical
trial population.
Setting: The data reported were collected as part of
the Danish Alzheimer’s Intervention Study (DAISY), a
longitudinal multicentre randomised controlled study
on the efficacy of psychosocial intervention in patients
with mild AD across five county districts in Denmark.
Participants: 321 patients with mild AD (Mini-Mental
State Examination ≥20) were included. Data regarding
current daily alcohol consumption were obtained from
the patient’s primary caregivers at inclusion.
Main outcome: All-cause mortality retrieved from
The Danish Civil Registration System over a period of
36 months after baseline.
Results: Information about alcohol consumption was
obtained from all 321 study participants: 8% were
abstinent, 71% only had alcohol occasionally (1 or
<1 unit/day), 17% had 2–3 units/day and 4% had more
than 3 units/day. An analysis adjusted for a range of
potential confounders demonstrated a reduced
mortality for patients with moderate alcohol
consumption (2–3 units/day): HR 0.23 (95% CI (0.08
to 0.69)) compared with patients who had 1 or <1 unit/
day. Mortality was not significantly different in
abstinent patients or in patients with an alcohol
consumption of more than 3 units/day, compared with
patients drinking 1 or <1 unit/day.
Conclusions: In this cohort of patients with mild AD,
moderate alcohol consumption (2–3 units/day) was
associated with a significantly lower mortality over a
period of 36 months. Further studies are needed in this
area. These may especially focus on the association
between alcohol consumption and cognitive decline in
patients with AD.
INTRODUCTION
It is a well-established fact that excessive
alcohol consumption has severe negative
effects on both physiological and psycho-
logical health. Several population cohort
studies suggest, however, that alcohol con-
sumption may not be solely harmful. In fact,
moderate alcohol consumption seems to
have beneﬁcial effects on various parts of
our health, decreasing the risk of cardiovas-
cular disease and mortality.1 2
Systematic reviews and meta-analysis on the
association between alcohol consumption
and dementia have concluded that at
present there is no indication that
light-to-moderate alcohol consumption is
harmful to dementia.3 On the contrary, it
has been stated that there is substantial evi-
dence that light-to-moderate alcohol con-
sumption reduces the risk of dementia and
cognitive decline.4
Strengths and limitations of this study
▪ Data in this study are disease-specific for
Alzheimer’s disease (AD). This gives us import-
ant knowledge on how a very common lifestyle
factor such as alcohol affects the lives of people
diagnosed with AD specifically.
▪ Since extensive data were collected on each
patient in the Danish Alzheimer’s Intervention
Study (DAISY) study, we were able to adjust for
a wide range of potential confounders, which is
essential when studying the effects of alcohol
consumption.
▪ The results of this study are based on post hoc
analysis, that is, the investigation of alcohol
intake on mortality was not described in the ori-
ginal DAISY protocol.
▪ In the alcohol groups, other than our reference
group (1 or <1 unit/day), the number of study
participants was relatively low.
▪ The participants in this study have been specific-
ally selected for an intervention study and there
might therefore be an over-representation of
better functioning patients. Patients with more
severe disease, those with significant comorbid-
ity and patients living in a nursing home without
a primary caregiver might have other effects of
alcohol.
Berntsen S, et al. BMJ Open 2015;5:e007851. doi:10.1136/bmjopen-2015-007851 1
Open Access Research
group.bmj.com on December 11, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
While there are numerous studies focusing on alcohol
as a risk factor for dementia and mortality in healthy
subjects, virtually no attention has been paid to the
effect of alcohol consumption in patients with
Alzheimer’s disease (AD).
It has been argued that social drinking may be
harmful for patients with AD;5 however, we have not
been able to identify any studies on the association
between alcohol consumption and mortality in patients
diagnosed with dementia. Considering that AD is a neu-
rodegenerative disorder and that alcohol has known
neurotoxic effects, one could easily jump to the conclu-
sion that alcohol is damaging for patients with AD. The
aim of this study was to investigate whether the positive
association between moderate alcohol intake and mor-
tality shown in population-based studies on healthy sub-
jects can be transferred to patients with mild AD.
METHODS
The data reported in this post hoc analysis were col-
lected as part of the Danish Alzheimer’s Intervention
Study (DAISY), a longitudinal multicentre study on the
efﬁcacy of a psychosocial intervention in patients with
mild AD in ﬁve county districts in Denmark. Details of
the background, cohort and methods of the study have
been reported earlier.6–8 Brieﬂy, this multicentre,
rater-blinded, randomised controlled study (RCT)
included 330 outpatients with mild AD, or dementia
with Lewy bodies, and their 330 primary caregivers. The
participants were randomised to control support during
follow-up or to control support plus DAISY intervention
(multifaceted and semitailored counselling, support and
education) over a period of 12 months. The follow-up
period was 3 years. The aim of the original DAISY study
was to assess the efﬁcacy at 12 months of an early psycho-
social counselling and support programme for outpati-
ents with mild AD and their primary caregivers. For the
present study, only patients with AD (n=321) were
included.
Participants
Inclusion criteria for the patients were: (1) a
Mini-Mental State Examination (MMSE) score ≥20,
(2) a clinical diagnosis within the past 12 months of
probable AD or mixed AD with vascular components, (3)
age ≥50 and (4) having a primary caregiver willing to
participate in the study. The patients met the
Diagnostic and Statistical Manual of Mental Disorders,
4th Edition9 criteria for dementia and the
NINCDS-ADRDA10 criteria for probable AD. Patients
were excluded if they lived in a nursing home, partici-
pated in other intervention studies or if they had
severe somatic or psychiatric comorbidity (including
signiﬁcantly impaired hearing or vision). Written
informed consent to participate was obtained from all
patients and primary caregivers.
Assessment of alcohol intake
At inclusion, the caregivers were asked about the
patient’s current average daily intake of alcohol.
The caregivers were asked in a questionnaire to assess:
‘Alcohol consumption—current daily intake (tick off
one box): no alcohol, only at parties, 1 or <1 unit/day,
2–3 units/day or more than 3 units/day’. Alcohol con-
sumption was not divided into types of alcoholic bev-
erages (beer, wine, spirits, etc).
Owing to the similar raw 3-year mortality (18.4% and
20.2%) and since the two classiﬁcations were overlap-
ping, the groups ‘only at parties’ and ‘1 or <1 unit/day’
were compiled under the title ‘1 or <1 unit/day’.
The Danish unit of alcohol was used in the study. A
Danish unit of alcohol is 12 g/15 mL of pure alcohol (a
UK unit of alcohol is 10 mL of pure alcohol.)
Assessment of mortality
Mortality data were retrieved from The Danish Civil
Registration System.11
Assessment of confounders
A number of potential confounders were recorded in
order to adjust the analysis: age, sex, smoking, house-
hold status, MMSE, quality of life (QoL), awareness, edu-
cation level and comorbidity.
MMSE was used to assess global cognitive functions.
Scores ranged from 20 to 26 at inclusion, with higher
scores indicating better cognitive performance.12
QoL (rated by the primary caregivers of the patient
with AD) was assessed with the quality of life Scale for
AD (QoL-AD).13 This is a 13-item scale ranging from 13
to 52. Higher scores indicate a better QoL.
The Alzheimer’s disease Cooperative Study activities of
daily living (ADSC-ADL) scale was used to assess activ-
ities of daily living. It is a 23-item scale with a maximum
score of 78. Higher scores indicate better function.14
On the basis of cognitive testing and interviews, the
patient’s level of awareness was rated with the
Anosognosia Rating Scale, which is a categorical three-
point scale from Reed et al.15 Awareness was classiﬁed
into ‘full awareness’, ‘shallow awareness’ and ‘no
awareness’.
Charlson Comorbidity Index (CCI) is a measure for
the general mortality increase due to disease.16 Starting
at the lowest score of zero, for each one of 19 different
conditions a weight is added to the index if a hospital
contact for this condition was recorded for a patient in
the 3 years before the dementia diagnosis; more severe
diagnoses had higher weights. Additionally, one point
was added for each 10 years of age above 40 years.
Education level was recorded in six groups: no educa-
tion, vocational, short education (<3 years), medium
education (3–4 years), long education (>4 years) and
other.
The groups ‘vocational’, ‘short education’ and ‘other’
were collapsed into one category in our statistical ana-
lyses (=vocational/short). The same applies for ‘Medium
2 Berntsen S, et al. BMJ Open 2015;5:e007851. doi:10.1136/bmjopen-2015-007851
Open Access
group.bmj.com on December 11, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
education’ and ‘long education’ that were also collapsed
into one category (=medium/long).
Statistical analysis
Baseline characteristics of the patients with various
degrees of alcohol consumption were compared using
Pearson’s χ2 test for categorical variables and a non-
parametric Kruskal-Wallis test for continuous variables.
The mortality associated with alcohol consumption
was estimated by HR from a Cox regression model. The
group ‘one or less than 1 unit/day’ was used as the
index group. Regression analysis was performed both
unadjusted and adjusted in a multivariable model for
possible confounders (age, sex, MMSE, QoL-AD,
ADSC-ADL, CCI, smoking, education and household
status) to check whether apparent associations could be
attributed to confounding.
Furthermore, the analysis was adjusted for the RCT
allocation group to rule out that a previously observed
increased mortality in the intervention group could be
attributed to differences in alcohol consumption.6
Subgroup analyses into a possible difference between
sexes, presence of comorbidity and whether the patient
was living alone in the association of alcohol intake with
mortality were tested by including an interaction term in
the regression analyses. Furthermore, sensitivity analyses
were performed omitting the patients reporting drink-
ing alcohol ‘only at parties’, and omitting event in the
ﬁrst year of follow-up.
Statistical analysis was done using SAS V.9.4.
RESULTS
Information about alcohol consumption was obtained
from all 321 study participants. Among these, 8% were
abstinent, 71% only had alcohol occasionally (1 or less
unit/day), 17% had 2–3 units/day and 4% had more
than 3 units/day.
Table 1 shows the baseline characteristics of the study
population according to categories of alcohol consump-
tion. There were relatively more abstinent women than
men and a higher percentage of men in the group of
patients with higher alcohol consumption (more than
3 units/day). The number of ‘never smokers’ decreased
with increasing alcohol consumption and there was a
tendency towards people living alone generally drinking
less than people living with others.
During the 36-month follow-up period, 53 (16.5%)
patients died. The effect of alcohol consumption on
mortality is shown in table 2. The multivariable analysis
demonstrated a reduced mortality for patients with mod-
erate alcohol consumption (2–3 units/day): HR 0.23
(95% CI (0.08 to 0.69) p=0.0076) compared to patients
who only had alcohol occasionally (1 or <1 unit/day).
Abstinent patients or patients with an alcohol consump-
tion of more than 3 units/day did not have signiﬁcantly
different mortality than patients drinking occasionally,
HR 0.81 (95% CI (0.28 to 2.35) p=0.70) and HR 1.51
(95% CI (0.43 to 5.30) p=0.52), respectively.
An analysis equal to the primary analysis, except that
the reference group is set to ‘2–3 units per day’ (table 3),
shows that this category has a signiﬁcantly lower risk com-
pared to ‘One or less than 1 unit/day’ (already seen in
table 2), as well as a signiﬁcantly lower risk than ‘More
than 3 units per day’.
Subgroup analyses showed no evidence of differential
effects of alcohol intake between sex (p=0.92), the pres-
ence or absence of comorbidity (p=0.76) or whether the
patient lived alone or with the primary caregiver
(p=0.78) (table 4). Omitting the subcategory ‘Only at
parties’ from the analyses resulted in similar results as
the primary analyses (table 4). Omitting the events in
the ﬁrst follow-up year from the analyses also gave
results similar to the primary analyses (table 4).
The applicability of the Cox model was conﬁrmed by
a graphical check of the proportional hazard assump-
tion in a Kaplan-Meier plot, as shown in ﬁgure 1 in the
online supplementary appendix.
DISCUSSION
In this post hoc analysis, we found that in patients
recently diagnosed with AD, those who had a moderate
alcohol intake (2–3 units/day) had a signiﬁcantly lower
risk of death compared with those who only had alcohol
occasionally (1 or <1 unit/day), and with those who had
high alcohol intake (more than 3 units/day). Abstinence
or high alcohol intake did not signiﬁcantly raise mortal-
ity compared with those drinking only occasionally.
Alcohol consumption was equal in the two RCT alloca-
tion groups; hence, alcohol consumption did not
explain the mortality difference between the interven-
tion and control groups.
To the best of our knowledge, we are the ﬁrst to show
an association between alcohol and mortality in patients
with a diagnosis of AD. Previous studies have either
focused on alcohol consumption and the risk of devel-
oping dementia, or on alcohol consumption and mortal-
ity in healthy subjects.17 18
Data in this study are disease speciﬁc for AD. This
gives us important knowledge on how a very common
lifestyle factor such as alcohol affects the lives of people
diagnosed with AD speciﬁcally.
The association between alcohol and mortality in
healthy subjects has been described as a U-shaped or
J-shaped curve in earlier studies.17 19 In this study in
patients with dementia, we found that in abstinent
patients and in patients with high alcohol intake there
was no signiﬁcant increase or decrease in mortality. An
association that is suggestive of a protective effect
between alcohol and mortality was seen only in the
group of patients who had 2–3 units/day.
There are several possible explanations for the pro-
tective association between moderate alcohol intake and
mortality observed in our study: (1) small amounts of
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alcohol may have a health preserving effect per se as
indicated in studies in healthy subjects; (2) patients with
moderate alcohol intake may have a richer social envir-
onment, which has been shown to improve the QoL and
perhaps mortality; (3) the seemingly protective associ-
ation may be caused by bias due to the fact that some
patients with low intake may be in the terminal phase of
their life.
In earlier studies, there are a variety of proposed
explanations for the associations between moderate
alcohol consumption and mortality in healthy subjects.
Among these, evidence is perhaps strongest for
Table 1 Baseline characteristics of patients with mild AD who participated in DAISY
No alcohol
n=25
≤1 Unit/day
n=227
2–3 Units/day
n=57
More than 3 units/day
n=12
Test—p
value
Sex
Male 7 (28) 94 (41.4) 37 (64.9) 7 (58.3) 0.0026
Female 18 (72) 133 (58.6) 20 (35.1) 5 (41.7)
Age 76.4 (73.5–78.5) 77.4 (71.7–81.6) 77.3 (71.9–80.03) 75.3 (71.2–78.8) 0.64
Awareness of disease
Full awareness 7 (28) 72 (31.7) 15 (26.8) 2 (16.7) 0.62
Shallow awareness 14 (56) 130 (57.3) 35 (62.5) 10 (83.3)
No awareness 4 (16) 25 (11) 6 (10.7) 0 (0.0)
Smoking
Never 11 (44) 62 (27.3) 15 (26.3) 1 (8.3) 0.26
Ex-smoker 8 (32) 99 (43.6) 30 (52.6) 7 (58.3)
Smoker 6 (24) 66 (29.1) 12 (21.1) 4 (33.3)
MMSE 24 (22–26) 24 (22–26) 24 (22–26) 23.5 (21.5–26.0) 0.84
QoL-AD 33 (30–36) 33 (30–38) 35 (29–39) 34.5 (27.5–40.5) 0.70
ADSC-ADL 65 (55–70) 65 (55–72) 61 (53–69) 64.5 (53.0–69.5) 0.47
CCI
0 16 (64) 99 (43.6) 18 (31.6) 4 (33.3) 0.052
1 7 (28) 90 (39.7) 26 (45.6) 8 (66.7)
>1 2 (8) 38 (16.7) 13 (22.8) 0 (0.0)
Household status
Living alone 10 (40) 76 (33.5) 9 (15.8) 3 (25) 0.044
Living with others 15 (60) 151 (66.5) 48 (84.2) 9 (75)
RCT allocation group
Control 11 (44) 114 (50.2) 32 (56.1) 8 (66.7) 0.51
Intervention 14 (56) 113 (49.8) 25 (43.9) 4 (33.3)
Education
None 7 (28) 97 (42.7) 9 (15.8) 2 (16.7)
Vocational/short 8 (32) 67 (29.5) 9 (15.8) 2 (16.7)
Medium/long 10 (40) 63 (27.8) 39 (68.4) 8 (66.7)
Values are numbers (percentages) or median (IQR).
p Values where calculated with the Kruskal-Wallis test or the Pearson χ2 test.
ADSC-ADL, Alzheimer’s disease Cooperative Study activities of daily living scale; CCI, Charlson Comorbidity Index; DAISY, The Danish
Alzheimer Intervention Study; MMSE, Mini-Mental State Examination; QoL-AD, quality of life scale for Alzheimer’s disease (proxy rated); RCT,
randomised controlled trial.
Table 2 Effect of alcohol consumption on mortality in patients with mild Alzheimer’s disease (AD) with ≤1 unit/day at
baseline
Alcohol consumption, units/day
Number of deaths
(percentage of total number of
patients in the group)
HR unadjusted
(95% CI)
HR adjusted*
(95% CI)
No alcohol
n=25
4 (16) 0.83 (0.30 to 2.30) 0.81 (0.28 to 2.35)
≤1
n=227
42 (18.5) 1.0 (baseline) 1.0 (baseline)
2–3
n=57
4 (7.0) 0.35 (0.12 to 0.98) 0.23 (0.08 to 0.68)
More than 3
n=12
3 (25.0) 1.42 (0.44 to 4.57) 1.51 (0.43 to 5.30)
*Adjusted for: sex, age, Mini-Mental State Examination, quality of life AD, AD Cooperative Study activities of daily living, Charlson Comorbidity
Index, awareness, smoking, household status, education and randomised controlled trial allocation group.
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moderate alcohol consumption lowering mortality indir-
ectly by decreasing the risks of cardiovascular disease.2
However, other plausible explanations such as modiﬁca-
tion of inﬂammation by lowering of interleukin 6
levels,20 or increase in insulin sensitivity,21 have been
suggested.
Results concerning the effect of alcohol consumption
on the development of dementia are diverging, but most
studies have demonstrated a reduction in dementia and
risk of AD with moderate alcohol intake compared to
abstinence.4 22 23
It has been suggested that there are signiﬁcant differ-
ences in subjects’ abilities to metabolise alcohol, genetic
differences being a determining factor for alcohol
having either a protective or a harmful effect on cogni-
tive abilities in later life.24 It should be considered
whether this factor could be part of an explanation for
the impact of alcohol on mortality in patients with AD.
Regarding the importance of alcohol type when con-
sidering the risk of developing dementia, earlier studies
have not been in agreement. Some have argued that
only consumption of wine was associated with a lower
risk of dementia,25 26 while other studies observed no
difference between types of alcohol.27 28
When using ‘2–3 units per day’ as the reference
group, we found that those with moderate alcohol
consumption had a signiﬁcantly lower risk of mortality
than subjects with high alcohol intake. This points in
the direction that increased alcohol intake is only pro-
tective until a certain consumption level.
Several limitations of our study must be acknowledged.
The results of this study are based on post hoc analysis,
that is, the investigation of alcohol intake on mortality
was not described in the original DAISY protocol.7
However, the present research question was formulated
(in an unpublished protocol) before the analyses were
performed, and was not part of a portfolio of research
questions. Hence, we believe that our results do not
contain conﬁrmation bias.
In the alcohol groups, other than our reference group
(1 or <1 unit/day), the number of study participants was
relatively low. The group ‘More than 3 units per day’
especially had few participants. This could be the reason
for lack of power and therefore the lack of association
between alcohol and mortality in the groups ‘No
alcohol’ and ‘More than 3 units per day’. However, the
point estimates do not point towards an association.
In our questionnaires, we focused on the amount of
alcohol consumed. We did not address other aspects of
alcohol consumption that might be equally important.
This includes considering if the group of abstainers con-
tained both ex-drinkers and patients with lifelong
Table 3 Effect of alcohol consumption on mortality in patients with mild Alzheimer’s disease (AD) with 2–3 units/day at
baseline
Alcohol consumption, units/day
Number of deaths
(percentage of total number of
patients in the group)
HR unadjusted
(95% CI)
HR adjusted*
(95% CI)
No alcohol
n=25
4 (16) 2.35 (0.59–9.40) 3.50 (0.84–14.62)
≤1
n=227
42 (18.5) 2.84 (1.02–7.93) 4.30 (1.47–12.57)
2–3
n=57
4 (7.0) 1.0 (baseline) 1.0 (baseline)
More than 3
n=12
3 (25.0) 4.02 (0.90–17.98) 6.50 (1.38–30.68)
*Adjusted for: sex, age, Mini-Mental State Examination, quality of life AD, AD Cooperative Study activities of daily living, Charlson Comorbidity
Index, awareness, smoking, household status, education and randomised controlled trial allocation group.
Table 4 Sensitivity and subgroup analyses
No alcohol, n=25
(HR 95% CI)
≤1 unit/day,
n=227
(HR 95% CI)
2–3 units/day,
n=57
(HR 95% CI)
More than 3 units/
day, n=12
(HR 95% CI)
Test
(p value*)
Men 0.46 (0.06 to 3.53) 1.00 (baseline) 0.32 (0.10 to 0.96) 1.60 (0.34 to 7.50) 0.9170
Women 1.07 (0.30 to 2.82) 1.00 (baseline) 0.00 (no deaths) 1.31 (0.17 to 10.44)
No comorbidities 1.26 (0.35 to 4.56) 1.00 (baseline) 0.00 (no deaths) 2.05 (0.26 to 16.46) 0.7595
Comorbidities 0.36 (0.05 to 2.71) 1.00 (baseline) 0.35 (0.12 to 1.06) 1.21 (0.26 to 5.70)
Living alone 0.44 (0.055 to 3.54) 1.00 (baseline) 0.26 (0.030 to 2.21) 2.93 (0.37 to 22.94) 0.7765
Not living alone 1.11 (0.32 to 3.80) 1.00 (baseline) 0.23 (0.066 to 0.76) 1.21 (0.26 to 5.56)
Omitting ‘only at parties’ 1.23 (0.42 to 3.62) 1.00 (baseline) 0.36 (0.12 to 1.10) 1.07 (0.22 to 5.27)
First year events removed 0.46 (0.13 to 1.62) 1.00 (baseline) 0.14 (0.040 to 0.51) 0.99 (0.24 to 4.06)
*Test for interaction.
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abstinence and taking into account patterns of alcohol
consumption. Since units were not divided into types of
alcohol, we are unable to detect whether a possible pro-
tective association between moderate alcohol consump-
tion and mortality is limited to one type of alcohol, for
example, wine.
In this study, the amount of alcohol consumed by the
patient was not self-reported, but was assessed by the
primary caregiver and therefore less likely to be marred
with inaccuracy caused by dementia. However, we
cannot rule out that some patients took more alcohol
than was noticed by their primary caregivers, or that the
primary caregiver was not entirely accurate about the
amount of alcohol a patient consumed. Characteristics
of the caregivers might differ considerably between
dyads (patient and primary caregiver). Cognitive abilities
and the caregivers’ own alcohol consumption levels are
some of the things that are likely to have inﬂuenced
both the actual amount of alcohol consumed by the
patient and the amount reported.
We assessed alcohol consumption only once at inclu-
sion. It might have been more representative to obtain
measurements of alcohol consumption multiple times
throughout the participant’s lives after the AD diagnosis,
thus characterising long-term alcohol consumption pat-
terns for our patients with AD and possibly avoiding
measurement errors.
The participants in this study make up a relatively
homogeneous group of participants. They have been
selected for an intervention study and there might there-
fore be an over-representation of better functioning
patients. We analysed for some effect modiﬁcation in a
series of secondary analyses. Different effects of alcohol
intake are generally expected between sexes because the
ofﬁcial health authorities’ guidelines on drinking are
different for men and women based on the assumption
of biological differences in ethanol metabolism pro-
posed in earlier studies. In our analyses, no differing
effects were seen.
It is an obvious concern that perhaps participants con-
suming alcohol moderately are generally healthier and
consequently less likely to die in the follow-up period
than those who do not consume alcohol.
To rule this out, we adjusted for premorbid conditions
in our analysis by including CCI as a possible confoun-
der. To accommodate any doubt whether the statistical
correction fully controlled for differences in group com-
position concerning comorbidity, we performed a sub-
group analyses. This showed no evidence of differential
effects.
To rule out that the accuracy of ethanol reporting was
questionable if a primary caregiver did not live together
with the patient, a sensitivity analysis was performed that
excluded patients living alone. Again, no differing
effects were seen.
It can be speculated whether patients who are weak
and approaching their terminal phase of life will natur-
ally reduce their alcohol intake—a form of reverse
causality. In this case, the protective effect that was
found would be artiﬁcially inﬂated. To remove the worst
cases of reverse causality, the ﬁrst year of follow-up was
removed from the analysis in a sensitivity analysis. This
analysis retains the conclusions from the original
primary analysis with effects that point in the same direc-
tion. This strengthens our belief that moderate alcohol
intake is indeed associated with decreased mortality and
not an artefact of reverse causation.
There might be concerns about the pattern of intake
(binge drinking vs regular intake) in the groups ‘Only at
parties’ and ‘One or less than 1 unit/day’, which was
compiled under one group. However, omitting the sub-
category ‘Only at parties’ from the analyses resulted in
similar results as the primary analyses.
Since extensive data were collected on each patient in
the DAISY study, we were able to adjust for a wide range of
potential confounders, which is essential when studying
the effects of alcohol consumption. However, there are a
number of possible confounders that we did not adjust for.
These include social status, body mass index, medication
use and genetic factors such as apolipoprotein E.29
Other studies on alcohol and mortality have shown dif-
ferent curves for men and women. The non-signiﬁcant
interaction term between sex and alcohol intake found
in our analysis indicates that the association between
alcohol intake and mortality is similar for the two sexes
and it is not necessary to stratify for sex in these analysis.
Guidelines on AD management advise against exces-
sive alcohol consumption as a secondary preventive
measure,30 but we have not been able to identify any
guidelines concerning light-to-moderate alcohol con-
sumption. Worldwide, approximately 35 million people
currently suffer from dementia and the number is likely
to increase considerably over the years to come.31 32
The WHO data from 2003 show that approximately
94% of the Danish population had consumed alcohol in
the past 12 months.33 This shows us that there is likely to
be a considerable number of people with AD who drink
alcohol regularly. In view of that, more reﬂection should
be given as to how alcohol affects subjects with AD.
The results of our study point towards a potential, posi-
tive association of moderate alcohol consumption on mor-
tality in patients with AD. However, we cannot solely on
the basis of this study neither encourage nor advise against
moderate alcohol consumption in patients with AD.
Further studies are needed on this area. Studies on
the effect of alcohol on cognitive decline and disease
progression in patients with mild AD would be especially
interesting.
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